Key Financial Figures - Standalone (₹ in Lakhs)
Quarterly Performance (Q4 FY25):
- Total Income: ₹221.69
- Total Expenses: ₹398.93
- Profit before tax: (₹177.24)
- Exceptional items: ₹0
- Profit after tax: (₹175.22)
- Other Comprehensive Income: ₹0.27
- Total Comprehensive Income: (₹174.96)
- Basic EPS: (₹0.52)
- Diluted EPS: (₹0.52)
Annual Performance (FY25):
- Total Income: ₹974.86
- Total Expenses: ₹1,252.49
- Profit before tax: (₹277.63)
- Exceptional items: ₹0
- Profit after tax: (₹275.61)
- Other Comprehensive Income: ₹0.27
- Total Comprehensive Income: (₹275.35)
- Basic EPS: (₹1.24)
- Diluted EPS: (₹1.24)
Comparative Figures (Q4 FY24):
- Total Income: ₹552.61
- Profit after tax: ₹9.91
- Basic EPS: ₹0.07
Capital Structure:
- Paid-up equity share capital increased from ₹1,411.36 lakh (FY24) to ₹3,389.93 lakh (FY25)
- Other equity decreased from ₹1,987.40 lakh (FY24) to ₹1,712.06 lakh (FY25)
Segment-wise Performance (Standalone)
Revenue Breakdown:
- Manufacturing in Plastic Moulded Components: ₹34.95 (Q4 FY25), ₹778.68 (FY25)
- Other Income: ₹186.74 (Q4 FY25), ₹196.18 (FY25)
- Trading in rough emerald: ₹0 (Q4 FY25), discontinued
Segment Results:
- Manufacturing segment profit before interest and tax: ₹132.23 (Q4 FY25)
- Unallocable segment loss: (₹302.90) (Q4 FY25)
Consolidated Financial Results
Auditor's Opinion:
Qualified opinion issued by HKG & Associates due to disclaimer opinion on subsidiary Aunik IT Private Limited.
Key Issues with Subsidiary:
- Trade receivables of ₹2,343.08 lakh without third-party confirmation
- Trade payables of ₹2,298.01 lakh to Morpheus Care Limited without confirmation
- Unsecured loans taken from director in violation of Companies Act, 2013
- Net worth fully eroded with accumulated losses of ₹2.46 crores
- Going concern uncertainty
Consolidated Financials (₹ in Lakhs):
- Q4 FY25 Profit after tax: (₹175.92)
- FY25 Profit after tax: (₹277.59)
- Basic EPS: (₹1.25) for FY25
Cash Flow Statement (Standalone)
FY25 Performance:
- Net cash flow from operating activities: (₹1,720.56)
- Net cash flow from investing activities: (₹76.18)
- Net cash flow from financing activities: ₹1,760.95
- Net decrease in cash: (₹35.79)
- Closing cash balance: ₹38.09
Financing Activities Detail:
- Net proceeds from issue of equity shares: ₹1,978.56
- Net proceeds from borrowings: ₹210.62
- Repayment of borrowing: (₹428.23)
Assets and Liabilities Position
Standalone (as of March 31, 2025):
- Total Assets: ₹10,726.25 lakh
- Trade receivables: ₹9,246.38 lakh
- Inventories: ₹79.28 lakh
- Total Equity: ₹5,101.99 lakh
- Total Liabilities: ₹5,624.27 lakh
Consolidated (as of March 31, 2025):
- Total Assets: ₹13,142.14 lakh
- Trade receivables: ₹11,589.46 lakh
- Total Equity: ₹5,025.77 lakh
- Total Liabilities: ₹8,116.37 lakh
Board Meeting Details:
- Held on November 21, 2026, from 4:30 PM to 5:30 PM
- Approved audited results for quarter ended March 31, 2025
- Unaudited results for quarter ended September 30, 2026 to be disclosed separately
Additional Information
Accounting Policies:
- Prepared in compliance with Indian Accounting Standards (Ind AS)
- Figures regrouped for comparability with current period classification
- Segment reporting as per SEBI Listing Regulations